Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer who have failed selected previous treatments.

Phase 2

Pfizer

Sunitinib